Hyperfine Advances International Swoop System Model 2 Rollout and Highlights the Role of Portable MRI in Brain Health Awareness
Business Wire•22/10/2026•08:15 ET
0
Key Highlights
- ➤CE mark and UKCA approvals expand Optive AI software’s European commercialization support
- ➤Model 2 sales reached four international markets within months of Europe launch
- ➤Swoop system Model 2 adopted by flagship institutions in the UK, France, and Romania
- ➤Optive AI update adds improved image quality, guided workflow, and isotropic T1 imaging
- ➤Notes and Neurons showcases Swoop live scanning across six German symphonic performances
Expert Statements
Eric Willis, Vice President of International at Hyperfine
“The European approval of Model 2 was an important milestone in Hyperfine's international growth strategy and early adoption in key European markets demonstrates progress in the company's international commercialization plan”
Maria Sainz, Chief Executive Officer of Hyperfine
“We have a long-standing relationship with researchers at the University of Bonn and are proud to support them in this innovative program by enabling them to bring brain imaging directly into the concert environment.”
Maria Sainz, Chief Executive Officer of Hyperfine
“Programs like Notes and Neurons highlight how portable MRI can help study the brain in entirely new settings while making brain health more accessible to the public. We are also seeing increasing commercial interest in the potential role of the Swoop system in brain health applications worldwide, representing an exciting opportunity for future growth.”
Hyperfine Advances International Swoop System Model 2 Rollout and Highlights the Role of Portable MRI in Brain Health Awareness
Latest Optive AI™ software receives CE mark and UKCA approvals, supporting the ongoing Swoop system Model 2 rollout, already underway in four international markets; “Notes and Neurons” showcases portable brain imaging in a German music and brain-health awareness series.
Get started
Create a free account to read the full story.